Perfusion MRI for Multi-site Studies of Brain Function
Perfusion MRI for Multi-site Studies of Brain Function
批准号:
9249105
负责人:
DAVID Charles ALSOP
金额:
$62.33万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-27 至 2019-03-31
关键词:
AchievementAddressAffectAlprazolamAnti-Anxiety AgentsAnxietyAttentionBiological MarkersBloodBrainBrain DiseasesBrain regionCaffeineCerebrovascular CirculationCitalopramClinical ResearchCommunitiesConfusionCoupledCustomDataDetectionDevelopmentDiagnosisDiseaseElementsEmotional disorderFunctional ImagingFundingGrantImageImage AnalysisImaging TechniquesIndividualInstructionInterventionIntervention StudiesInvestigationLiteratureMagnetic Resonance ImagingMeasurementMeasuresMedicalMental disordersMetabolismMethodologyMethodsMonitorMulticenter StudiesNicotineNoisePathologyPatternPerformancePerfusionPharmaceutical PreparationsPharmacologic ActionsPhysiologic pulsePhysiologicalProtocols documentationReportingReproducibilityResearchResearch PersonnelRestSample SizeScanningSelection for TreatmentsServicesSignal TransductionSiteSourceSpin LabelsStimulusTechniquesTechnologyTestingTimeUncertaintyVariantVendorWorkbrain metabolismdesignexperienceimage processingimaging studyimprovedindividual patientmental statenervous system disorderneural correlateneuroimagingpreferencepublic health relevancequality assuranceresponsevigilancevolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Arterial Spin Labeling (ASL) perfusion MRI shows promise as a widely available and quantitative measure of resting brain function that can be used as a biomarker for the neural correlates of psychiatric and neurologic diseases, for the measurement of drug effects in the brain, and ultimately for diagnosis and treatment monitoring in individual patients. Although ASL perfusion MRI technologies are now implemented on most MRI scanner platforms, uncertainty in the community on the performance differences of various technical implementations and how to best use the technology across centers and MRI scanner platforms has limited its dissemination into routine use in clinical research. Building upon our successful development of quantification methods and standard sequences across platforms in the prior funding cycle, we propose to focus on the key issues limiting multi-center studies with ASL. Our first aim is to measure the relative sensitivity of different implementations of ASL by comparing their reproducibility and their response to 2 test interventions, citalopram or alprazolam administration. The result of this aim will be a quantitative calculation of power for detection of regional effects and how the choice of implementation will affect the power and required sample size. The second aim is to develop quality assessment methods using customized image acquisitions and the construction of a perfusion phantom. Quality assurance is a key element of imaging studies across sites, but there are no established methods for testing ASL perfusion performance. In our final aim, we target the characterization and reduction of variable perfusion signal induced by changes in brain activity unrelated to study interventions, so-called physiological noise. We will determine whether performing a moderately demanding vigilance task during the ASL scan will help control the subject's mental state and reduce variability without excessively stimulating particular regions of the brain. We will also study resting fluctuations in perfusion induced by network activity in the brain to determine if identifying and removing these fluctuations during image processing improves reproducibility. This aim will also determine if the amplitude of resting fluctuations is reflective of resting perfusion. Since resting brain fluctuations as measured by blood oxygenation sensitive MRI are increasingly being used as an indicator of resting function, establishing a relationship between fluctuations and average resting activity will address an outstanding question in functional imaging. Achievement of these aims will accelerate and improve the use of ASL as a biomarker for brain function in disease and will greatly improve the design of numerous planned and active multi-site studies employing ASL.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1186/s12987-020-00218-z
发表时间:
2020-09-22
期刊:
Fluids and barriers of the CNS
影响因子:
7.3
作者:
[Zhao L, Taso M, Dai W, Press DZ, Alsop DC]
通讯作者:
Alsop DC
DOI:
10.1016/j.neuroimage.2020.117371
发表时间:
2020-12
期刊:
NEUROIMAGE
影响因子:
5.7
作者:
[Munsch, Fanny, Taso, Manuel, Zhao, Li, Lebel, R. Marc, Guidon, Arnaud, Detre, John A., Alsop, David C.]
通讯作者:
Alsop, David C.
DOI:
10.1109/tmi.2016.2615567
发表时间:
2017-02
期刊:
IEEE transactions on medical imaging
影响因子:
10.6
作者:
[Zhao L, Dai W, Soman S, Hackney DB, Wong ET, Robson PM, Alsop DC]
通讯作者:
Alsop DC
DOI:
10.1007/s10334-011-0286-3
发表时间:
2012-04
期刊:
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
影响因子:
2.3
作者:
[Maleki, Nasim, Dai, Weiying, Alsop, David C.]
通讯作者:
Alsop, David C.
Perfusion MRI for Multi-site Studies of Brain Function
-
批准号:8820281
-
项目类别:
-
资助金额:$62.55万
-
财政年份:2007
-
负责人:DAVID Charles ALSOP
-
依托单位:
Perfusion MRI for Multi-site Studies of Brain Function
-
批准号:8653375
-
项目类别:
-
资助金额:$71.35万
-
财政年份:2007
-
负责人:DAVID Charles ALSOP
-
依托单位:
Perfusion MRI for Multi-site Studies of Brain Function
-
批准号:9045707
-
项目类别:
-
资助金额:$62.55万
-
财政年份:2007
-
负责人:DAVID Charles ALSOP
-
依托单位:
Blood Flow MRI for Monitoring Glioma Angiogenesis
-
批准号:7916808
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2006
-
负责人:DAVID Charles ALSOP
-
依托单位:
Blood Flow MRI for Monitoring Glioma Angiogenesis
-
批准号:7459506
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2006
-
负责人:DAVID Charles ALSOP
-
依托单位:
Blood Flow MRI for Monitoring Glioma Angiogenesis
-
批准号:7094455
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2006
-
负责人:DAVID Charles ALSOP
-
依托单位:
Blood Flow MRI for Monitoring Glioma Angiogenesis
-
批准号:7278247
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2006
-
负责人:DAVID Charles ALSOP
-
依托单位:
Blood Flow MRI for Monitoring of Renal Cell Carcinoma
-
批准号:7159064
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2006
-
负责人:DAVID Charles ALSOP
-
依托单位:
Blood Flow MRI for Monitoring of Renal Cell Carcinoma
-
批准号:7282698
-
项目类别:
-
资助金额:$29.3万
-
财政年份:2006
-
负责人:DAVID Charles ALSOP
-
依托单位:
Diagnostic Imaging of Cerebral Blood Flow with MRI
-
批准号:6644750
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2000
-
负责人:DAVID Charles ALSOP
-
依托单位:
Diagnostic Imaging of Cerebral Blood Flow with MRI
-
批准号:6348799
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2000
-
负责人:DAVID Charles ALSOP
-
依托单位:
Diagnostic Imaging of Cerebral Blood Flow with MRI
-
批准号:6533922
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2000
-
负责人:DAVID Charles ALSOP
-
依托单位:
Diagnostic Imaging of Cerebral Blood Flow with MRI
-
批准号:6372560
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2000
-
负责人:DAVID Charles ALSOP
-
依托单位:
海外基金